Press Release: Zepp Health Corporation Reports Third Quarter 2024 Unaudited Financial Results

Dow Jones11-19
Share-based compensation 
 expenses                                       7,013                3,827 
                                 --------------------  ------------------- 
Adjusted operating loss                      (24,063)             (34,485) 
                                 --------------------  ------------------- 
 
Net loss                                     (29,822)             (38,907) 
Share-based compensation 
 expenses                                       7,013                3,827 
Income tax (benefits)/expenses                (5,205)                  119 
Interest income                               (2,264)              (2,901) 
Interest expense                                5,314                4,105 
Adjusted EBIT                                (24,964)             (33,757) 
                                 --------------------  ------------------- 
 
Net loss attributable to Zepp 
 Health Corporation                          (29,741)             (38,857) 
Share-based compensation 
 expenses                                       7,013                3,827 
                                 --------------------  ------------------- 
Adjusted net loss attributable 
 to Zepp Health Corporation([) 
 (2])                                        (22,728)             (35,030) 
                                 ====================  =================== 
Adjusted net loss per share 
attributable to  Zepp Health 
Corporation 
Adjusted basic loss per 
 ordinary share                                (0.09)               (0.14) 
Adjusted diluted loss per 
 ordinary share                                (0.09)               (0.14) 
 
Adjusted net loss per ADS (16 
ordinary shares equal to 
1 ADS)([3]) 
ADS -- basic                                   (1.49)               (2.16) 
ADS -- diluted                                 (1.49)               (2.16) 
 
Weighted average number of 
shares used in computing 
adjusted net loss per share 
Ordinary share -- basic                   243,679,883          259,433,512 
Ordinary share -- diluted                 243,679,883          259,433,512 
 
Share-based compensation 
expenses included  are 
follows: 
Selling and marketing                             497                  368 
General and administrative                      3,154                1,812 
Research and development                        3,362                1,647 
                                 --------------------  ------------------- 
Total                                           7,013                3,827 
                                 --------------------  -------------------

View original content:https://www.prnewswire.com/news-releases/zepp-health-corporation-reports-third-quarter-2024-unaudited-financial-results-302308549.html

SOURCE Zepp Health Corp.

(END) Dow Jones Newswires

November 18, 2024 20:00 ET (01:00 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment